However, its prognostic relevance was not yet addressed in the HIV-infected context, even though cMYC (179) and BCL2 (194) expression were described separately as prognostic factors for HIV-DLBCL. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.